Royal Bank Of Canada Allakos Inc. Transaction History

Royal Bank Of Canada

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.0 - $1.45 $223 - $323	-223 Reduced 9.98%	2,012 $2,000
Q1 2024 Nov 05, 2024	BUY	$1.02 - $3.23 $227 - $720	223 Added 11.08%	2,235 $2,000
Q1 2024 May 15, 2024	SELL	$1.02 - $3.23 $17,365 - $54,990	-17,025 Reduced 88.4%	2,235 $2,000
Q4 2023 Feb 14, 2024	BUY	$1.72 - $3.18 $13,901 - $25,700	8,082 Added 72.3%	19,260 $52,000
Q3 2023 Nov 14, 2023	BUY	$2.13 - $5.55 $8,262 - $21,528	3,879 Added 53.14%	11,178 $25,000
Q2 2023 Aug 14, 2023	BUY	$3.6 - $5.25 $26,247 - $38,277	7,291 Added 91137.5%	7,299 $31,000
Q1 2023 May 15, 2023	SELL	$4.3 - $8.27 $700 - $1,348	-163 Reduced 95.32%	8 $0
Q4 2022 Feb 14, 2023	SELL	$5.66 - $8.42 $62 - $92	-11 Reduced 6.04%	171 $1,000
Q3 2022 Nov 14, 2022	BUY	$3.02 - $6.12 $549 - $1,113	182 New	182 $1,000
Q2 2022 Aug 15, 2022	SELL	$2.6 - $6.14 $5,665 - $13,379	-2,179 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$5.08 - $9.81 $33,771 - $65,216	-6,648 Reduced 75.31%	2,179 $12,000
Q4 2021 Feb 14, 2022	BUY	$8.55 - $111.89 $19,408 - $253,990	2,270 Added 34.62%	8,827 $87,000
Q3 2021 Nov 15, 2021	SELL	$76.53 - $110.43 $217,268 - $313,510	-2,839 Reduced 30.21%	6,557 $694,000
Q2 2021 Aug 16, 2021	BUY	$85.37 - $114.1 $802,136 - $1.07 Million	9,396 New	9,396 $802,000

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $108M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.